Contrast Media & Molecular Imaging / 2020 / Article / Tab 2

Research Article

Contrast-Enhanced Ultrasound Evaluation of Mifepristone for Treatment of Low-Risk Cesarean Scar Pregnancy

Table 2

CEUS perfusion quantification before and after mifepristone treatment in CSP and IUP patients.

GroupParameterBefore mifepristone treatmentAfter mifepristone treatmentt

CSP (n = 23)AT (s)18.42 ± 3.3813.39 ± 1.988.117≤0.001
PI (dB)17.68 ± 2.8414.48 ± 2.816.446≤0.001
AUC1011.03 ± 194.53800.33 ± 109.418.341≤0.001
IUP (n = 23)AT (s)18.71 ± 2.0114.06 ± 2.857.208≤0.001
PI (dB)17.85 ± 2.6115.47 ± 2.444.411≤0.001
AUC1041.76 ± 168.14878.49 ± 162.2310.961≤0.001

AT, arrival time; AUC, the area under the time intensity curve; CEUS, contrast-enhanced ultrasonography; CSP, cesarean scar pregnancy; IUP, intrauterine pregnancy; PI, peak intensity.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.